A New Path Forward for Severe Alopecia Areata Sun Pharmaceuticals has officially launched Leqselvi (deuruxolitinib)—an oral JAK1/JAK2 inhibitor—for adults with severe alopecia areata in the United States. The rollout follows the resolution of a patent dispute with Incyte, a legal roadblock that had delayed the drug’s entry into the U.S. market. Now, the 8 mg tablets […]